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Highlights 
 
 TPPP/p25 is expressed in oligodendrocytes and some amacrine cell bodies in 
the eye 
 In the inner plexiform layer of the retina TPPP/p25 is expressed in postsynap-
tic dendrites 
 Zinc supplementation elevates the levels of TPPP/p25 in the inner plexiform 
layer 
 Zinc could play a role in the integration of visual stimulus in the retina 
 
 
Graphical abstract 
 
 
 3 
ABSTRACT 
Tubulin Polymerization Promoting Protein (TPPP/p25) modulates the dynamics 
and stability of the microtubule network by its bundling and acetylation enhancing ac-
tivities that can be modulated by the binding of zinc to TPPP/p25. Its expression is 
essential for the differentiation of oligodendrocytes, the major constituents of the mye-
lin sheath, and has been associated with neuronal inclusions. In this paper, evidence 
is provided for the expression and localization of TPPP/p25 in the zinc-rich retina and 
in the oligodendrocytes in the optic nerve. Localization of TPPP/p25 was established 
by confocal microscopy using calbindin and synaptophysin as markers of specific stri-
ations in the inner plexiform layer (IPL) and presynaptic terminals, respectively. 
Postsynaptic nerve terminals in striations S1, S3 and S5 in the IPL and a subset of 
amacrine cells show immunopositivity against TPPP/p25 both in mice and human 
eyes. The co-localization of TPPP/p25 with acetylated tubulin was detected in ama-
crine cells, oligodendrocyte cell bodies and in synapses in the IPL. Quantitative West-
ern blot revealed that the TPPP/p25 level in the retina was 0.05-0.13 ng/μg protein, 
comparable to that in the brain. There was a central (from optic nerve head) to periph-
eral retinal gradient in TPPP/p25 protein levels. Our in vivo studies revealed that the 
oral zinc supplementation of mice significantly increased TPPP/p25 as well as acety-
lated tubulin levels in the IPL. These results suggest that TPPP/p25, a microtubule 
stabilizer can play a role in the organization and reorganization of synaptic connections 
and visual integration in the eye. 
 
Keywords: Tubulin Polymerization Promoting Protein, retina, inner plexiform layer, 
amacrine cell, zinc, myelin sheath  
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INTRODUCTION  
Tubulin Polymerization Promoting Protein (TPPP/p25) is a 25 kDa disordered 
microtubule-associated protein that was first identified in the brain [1] where it plays a 
crucial role in the differentiation of oligodendrocytes [2] and is involved in the develop-
ment, maintenance and stability of oligodendrocyte projections due to the modulation 
of the dynamics and stability of microtubule network [3-5]. Oligodendrocytes are the 
major constituents of the myelin sheath. TPPP/p25 directly interacts with histone 
deacetylase 6, inhibits its activity, and therefore regulates acetylation of tubulin [5] and 
influence differentiation, cellular polarization and migration [6-9].  
While the normal function of TPPP/p25 is to modulate and stabilize the micro-
tubule network [3-5] by it bundling and acetylation enhancing activity due to its inter-
action with tubulin deacetylases (histone deacetylase 6, sirtuin 2), it can also directly 
interact with α-synuclein [10], hallmark protein of synucleinopathies,  and play a role in 
its pathological oligomerisation/aggregation. TPPP/p25 is implicated in the develop-
ment of synucleinopathies such as Parkinson’s disease and Multiple System Atrophy, 
when α-synuclein and TPPP/p25 are co-localized and co-enriched in the inclusions 
[11-14].  
TPPP/p25 has a zinc binding motif [15, 16], the specific binding of the bivalent 
zinc cation to TPPP/p25 induces structural changes/dimerization coupled with stabili-
zation that counteracts its proteolytic degradation [17]. Thus, zinc may control the in-
tracellular level of TPPP/p25, playing role in its physiological as well as its pathological 
functions [17]. Zinc levels can be altered in different diseases of the eye [18] and a 
recent study showed that optic nerve (ON) injuries can elevate zinc levels not only in 
the ON but also in the retina [19]. In this paper, we set out to investigate whether the 
intracellular TPPP/p25 level could be affected by the zinc level.  
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MATERIALS AND METHODS 
 
Antibodies – The list of antibodies used for the experiments can be found in Supple-
mentary Table 1. 
 
Human eyes - Five whole human eyes with no known pathological conditions were 
obtained from the Boston University and the UCL Institute of Ophthalmology Eye De-
positories within 24 hours of death. In addition, paraffin sections from six eyes from the 
UCL Institute of Ophthalmology pathological archive were also used. Full Local Re-
search Ethics Committee approval and appropriate consent was obtained in each 
case. The protocol of the study adhered to the tenets of the Declaration of Helsinki 
regarding research involving human tissue. 
 
Mouse eyes – Eyes from 6 months old female mice were used in this study from a 
previous experiment in which zinc supplementation had a significant behavioural effect 
[20]. The eyes were dissected from double transgenic mice overexpressing human 
APP and ApoE4 as well as wild type litter mates [20]. Four wild type and 4 transgenic 
animals were given drinking water without zinc supplementation to establish baseline. 
In addition, 4 transgenic mice were given drinking water supplemented with 10 ppm 
(0.153 mM) zinc carbonate from the age of 2 months The zinc-enhanced water was 
prepared by dissolving 10,000 mg/L zinc in 5% HNO3 and adding Na2CO3 to buffer the 
solution to pH 7.0 [20].  
 
Preparation of human retina extract - Cell extracts were prepared from three unfixed 
human eyes that were flat mounted before peripheral and central retina tissues were 
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excised. After excision, the tissues were homogenized in buffer A (10 mM tris(hy-
droxymethyl)aminomethane, 150 mM NaCl, 5 mM ethylenediaminetetraacetic acid pH 
7.4 containing 1 μg/ml leupeptin, 1 μg/ml pepstatin, 10 μM 4-(2-aminoethyl) benzene-
sulfonyl fluoride hydrochloride, 1 mM benzamidine, 1% Triton X-100)  at a 1:4 ratio of 
tissue and buffer by a Potter-homogenizer. The homogenates were centrifuged at 
17000 g for 10 min at 4°C, and the supernatants were used for further experiments. 
Bovine brain extract was prepared similarly. The protein concentration of the ret-
ina/brain extract was determined by the Bradford method [21] using the Bio-Rad pro-
tein assay kit.  
 
Purification of human wild type TPPP/p25 and bovine tubulin - Human recombinant full 
length TPPP/p25 with a His-tag was expressed in E. coli BL21 (DE3) cells and isolated 
on HIS-Select™ Cartridge (Sigma-Aldrich) as described previously [11, 22]. Tubulin 
was prepared from bovine brain according to the method of Na and Timasheff [23]. 
TPPP/p25 concentration was determined from the absorbance at 280 nm using an 
extinction coefficient of 10095 M−1 *cm−1. 
 
Western blot - Retina samples were analysed by sodium dodecyl sulphate polyacryla-
mide gel electrophoresis, and were electrotransferred onto Immobilon-PSQ transfer 
membranes and labelled with antibodies: TPPP/p25 in a dilution of 1:5000 [11] or with 
tubulin (1:5000; Sigma T9026), acetylated tubulin (1:5000; Sigma T6793) or glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH) in mouse (1:25000 Calbiochem 
CB1001) (Supplementary Table 1). Antibody binding was revealed by using anti-rat or 
anti-mouse IgG coupled with peroxidase, ECL® (enhanced chemiluminescence) 
Western Blotting Detection reagents (Amersham Biosciences) and Chemidoc Image 
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system or 3-amino-9-ethylcarbazole as substrate. Images were analysed by Image-J 
using mean pixel intensity value tool kit. 
 
Immunocytochemistry - Eyes from human as well as mice were embedded in paraffin 
and 10 μm sections were collected on glass slides. Immunohistochemistry was per-
formed using monoclonal and polyclonal antibodies against several relevant proteins 
(see list in Supplementary Table 1). Primary antibodies were applied after antigen re-
trieval in citrate buffer (heating for 2 x 3 minutes for mice and 3 x 3 minutes for human 
samples in microwave at 750 W) followed by blocking for 1 hour in goat serum (1:20, 
Sigma G9023). Primary and secondary antibodies were applied for 1 hour at room 
temperature, washed 3 x 5 min with phosphate buffer saline (PBS). TPPP/p25 was 
visualized using Alexa-Fluor 488 Goat anti-rat secondary antibody (1:1000; Invitrogen 
A11006). Acetylated tubulin, calbindin and synaptophysin labelling were visualized us-
ing Alexa-Fluor 568 Goat anti-mouse secondary antibodies (1:1000; Sigma T7782). 
Nuclear staining was performed using Hoechst (0.001 g/ml, Life Technologies H3570). 
Samples were imaged using a Zeiss LSM700 confocal microscope through 40x or 
63x/1.2 NA Zeiss Neofluar objectives and images generated using the ZEN software 
package (Zeiss).  Central and peripheral retinal images were taken from each section. 
Sections from lab water or zinc fed animals were processed in parallel and microscope 
setting was kept standard between samples for the comparison of immunofluores-
cence intensities. Images were imported into Image-J and fluorescence intensities 
were analysed using mean pixel intensity value tool kit. 
 
Immunogold staining - Retina from an unfixed human eye was flat mounted and fixed 
in 3% formaldehyde and 0.2% glutaraldehyde overnight at 4°C, then washed in PBS. 
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The macular region was dissected and embedded in 3.6% agarose solution and vi-
bratome sections of 50 μm thickness were cut and collected in a 24 well plate in PBS. 
To visualize ultrastructural localization of TPPP/p25 in the retina, sections were pro-
cessed for pre-embedding immunogold labelling using methods modified from [24, 25]. 
The sections were washed in 50 mM glycine solution for 2 hours, then incubated in 10 
mM sodium citrate buffer (pH 6.0) for 15 mins using a variable wattage microwave 
(power at 200 Watts, sample temperature at 45°C; Pelco BioWave, Ted Pella) for an-
tigen retrieval. After rinsing (3x10 mins in PBS), sections were incubated in blocking 
solution (10% bovine serum albumin (BSA), 5% normal goat serum (NGS), 0.025% 
Triton-X in PBS) for 1 hour at room temperature. Sections were incubated with the 
rabbit polyclonal primary antibody against TPPP/p25 (1:100, Novusbio NBP1-80962), 
first in the microwave (5 mins at 150W, 35°C) and then at 4°C overnight. Sections were 
rinsed (3x10 mins in 10 mM phosphate buffer with 0.2% Aurion BSA-c) and then incu-
bated in a 6 nm gold-conjugated goat anti-rabbit secondary FAB2 IgG (1:50, Aurion) 
in the microwave (5 mins at 150W, 35°C), followed by incubation overnight at 4°C. The 
antibody was diluted in PBS, 0.2% acetylated BSA (BSA-c; Aurion) and 0.025% Triton-
X. After antibody incubation steps, sections were rinsed in PBS with 0.2% BSA-c, fol-
lowed by quick rinses in 20 mM sodium citrate buffer (pH 7.0, 5 mins) then distilled 
water (1 min). Sections were then processed for silver enhancement of gold-particles, 
using R-Gent SE-EM kit (Aurion; 60-90 mins), for better visualization of gold label. After 
rinses in water and PBS, sections were post-fixed in 6% glutaraldehyde and 2% para-
formaldehyde solution. Samples were heated in a microwave until sample tempera-
tures reached 30°C (4x5 min 200W). The labelled retina samples were osmicated in 
1% osmium solution for 30 minutes at room temperature, incubated in 1.5% aqueous 
uranyl acetate solution for 90 mins, dehydrated and embedded in Epon-Araldite resin. 
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Ultra-thin sections of 70-90 nm thickness were cut and collected on pioloform coated 
copper slot grids. The samples were imaged using at 80kV JOEL JEM-1010 transmis-
sion electron microscope. 
 
Statistical analysis - Representative experiments were analysed using Wilcoxon 
matched-pairs signed rank test to determine differences between two groups. When 
more than two groups were analysed two results were compared with 2-way ANOVA. 
p-values of less than 0.05 were considered significant: *p < 0.05. 
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RESULTS  
TPPP/p25 in the mouse eye 
First, we determined the immunolocalization of TPPP/p25 in the ON in mice eyes. The 
myelin sheath around the ON axons is formed by oligodendroglia and TPPP/p25 has 
been shown to be present and play a crucial role in the differentiation of oligodendro-
cytes in the brain [2]. As predicted, there was a strong immunopositivity for TPPP/p25 
present in oligodendrocytes in the ON (Fig. 1). We found strong TPPP/p25 labelling in 
the myelinated portion of the ON (Fig. 1A1), where the labelling was associated with 
cell bodies and structures resembling oligodendrocytes and fibres, respectively (Fig. 
1A2, insert). Immunolabelling was terminated close to the entry of ON into the eye (Fig. 
1A1) at the area  known to be devoid of myelin [26] due to the presence of the lamina 
cribrosa that prevents the entry of oligodendrocyte precursor cells into the eye to pre-
vent interference with light processing [27, 28]. These observations on mice ON pro-
vided support for the specificity of the antibodies we used in our experiments.  
TPPP/p25 was localized to the inner plexiform layer (IPL) (Fig 1A1 and 1B2) in sublam-
ina S1, S3 and S5 as distinct puncta (Fig. 1C). The area occupied by the different 
TPPP/p25 striations were S1=0-22%, S2=23-29%, S3=30-52%, S4=53- 60% and 
S5=61-100% where S1 was the closest to the inner nuclear layer (INL) and S5 to the 
ganglion cell layer (GCL) (Supplementary Table 2). The full width of the IPL was 100%. 
To confirm the definition of S2 and S4, we co-labelled sections with a calbindin specific 
antibody. Calbindin has been previously shown to localize to S2, S3 and S4 only [29, 
30]. Clearly, the labelling of calbindin interposes between the TPPP/p25 labelled 
sublaminas in S2 and S4 and co-localizes in S3 (Fig. 1G1-3). TPPP/p25 was enriched 
in a small subset of cell bodies in the INL and GCL in cells immediately adjacent to the 
IPL (Fig. 1 B2, C, F1 and G1). We also found TPPP/p25 immunopositive interplexiform 
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projections to the outer plexiform layer (OPL) through the INL (Fig. 1 D, arrow). Due to 
the punctate appearance of TPPP/p25 immunolabelling in the IPL we speculated that 
the protein was associated with presynaptic terminals. To determine whether this lo-
calization is pre- or postsynaptic we co-labelled sections with TPPP/p25 (Fig. 1F1) and 
the presynaptic marker synaptophysin (Fig. 1F2). The lack of co-localization (Fig. 1F3) 
suggested that TPPP/p25 is likely to be associated with postsynaptic boutons. This 
was most evident in the sublamina S5, where anti-synaptophysin positive nerve end-
ings were surrounded by TPPP/p25 positive structures (see supplementary Fig. S2). 
TPPP/p25 is involved in tubulin acetylation, therefore, we also assessed whether there 
is co-localization of TPPP/p25 and acetylated tubulin in the mouse eye. Acetylated 
tubulin immunoreactivity was present in the ON as well as in the IPL (Fig. 1A1) but it 
appeared that there are areas where there was a lack of co-localization (Fig 1E1-3). 
Acetylated tubulin immunoreactivity was associated with discrete filamentous struc-
tures in the IPL (Fig. 1B3 and E2; Supplementary figure S1) adjacent to the punctate 
labelling of TPPP/p25. Acetylated tubulin labelling was the strongest in sublamina S1 
and then uniformly distributed in S2-S5 (See supplementary Fig. S1 and Supplemen-
tary Table 2). Acetylated tubulin immunoreactivity was present throughout the retina 
(Supplementary figure S1).  
To examine further the co-localization of TPPP/p25 and acetylated tubulin, we gener-
ated line scans across the areas of interest (Fig 2). On the ON, there is clear and strong 
co-localization between the two proteins (Fig 2A). In the retina, there are areas with 
full co-localization, but there are areas in which only TPPP/p25 or acetylated tubulin 
was present (Fig 2B, arrow heads). 
Effect of zinc supplementation on TPPP/p25 level in mice 
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After determining TPPP/p25 localization we explored whether experimental manipula-
tion influences TPPP/p25 levels. It has been reported that zinc induced structural re-
arrangement of TPPP/p25 into the so called molten globule [15], increased TPPP/p25 
levels and tubulin polymerization at cellular level [16, 17]. Zinc is abundantly present 
in the retina [31] and zinc supplementation has a direct effect on the eye [ 32]. In addi-
tion, recent evidence shows ON injury can significantly increase zinc levels, especially 
in the IPL [19]. Therefore, we examined whether supplementation with zinc could affect 
TPPP/p25 and/or tubulin acetylation in the mouse eyes. We found that long term zinc 
supplementation has a lasting effect by significantly increasing TPPP/p25 immunore-
activity (Fig. 3A) as well as acetylated tubulin immunoreactivity (Fig 3B) in the IPL. 
These effects appear only to be significant in the central but not in the peripheral retina 
(Fig. 3). While the number of sample were low (n=3) to fully assess the sub-laminar 
changes the immunoreactivity of TPPP/p25 was increased in all striations, while acet-
ylated tubulin immunoreactivity appeared to increase only in S1 (Supplementary Table 
2).  
Localization of TPPP/p25 in the human retina 
Localization of TPPP/p25 in the human retina was carried out by labelling fixed and 
sectioned samples from 5 independent human cadaveric eyes with two different poly-
clonal antisera. TPPP/p25 immunopositivity was present in the IPL in sublamina S1, 
S3 and S5 forming distinct puncta (Fig. 4A). Cytosolic labelling was observed in a sub-
set of neuronal cells immediately adjacent to the IPL in the GCL as well as the INL 
(Fig. 4B, white arrows) with occasional interplexyform projections to the OPL (Fig 4B, 
red arrow). Imaging flat-mount retinas we found that <7% of the total numbers of cell 
(determined by counting labelled nuclei and immunopositive cells) adjacent to the IPL 
were labelled (Fig. 4C).  
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Based on their location immediately adjacent to the IPL we propose that the TPPP/p25 
positive cells are amacrine cells. Although the list is growing, over 45 different types of 
amacrine cells are identified at the inner and outer margin of the INL [30, 33]. Distin-
guishing amongst the major subtype of amacrine cells is possible by identifying the 
branching morphology or the neurotransmitter they are enriched in [30, 33]. We exam-
ined weather the cells in our experiments are GABA- or glycinergic [30, 34]. Co-label-
ling the retina with antisera against GABA or glycine and TPPP/p25 showed many 
GABA/glycine positive cells (Fig.5A and B, white arrows) but only partial co-localization 
with TPPP/p25 (Fig. 5 A and B; yellow/orange cell bodies). Therefore, no identification 
based on these neurotransmitters was found. In synaptic terminal in the IPL GABA did 
not co-localize with TPPP/p25 (Fig. 5C) but rather was positioned the opposing side of 
a synapse, suggesting, just as in mouse, that TPPP/p25 is a postsynaptic protein. To 
confirm its postsynaptic location human samples were labelled with immunogold for 
TPPP/p25 which then was silver enhanced for electron microscopy. Immunoelectron 
microscopy confirmed that TPPP/p25 was indeed in boutons with little or no synaptic 
vesicles, opposing vesicle-rich boutons (Fig 5D).  
Finally, we determined the concentration of TPPP/p25 levels in the human retina using 
retina extracts from three freshly dissected, unfixed cadaveric samples (from donor 
ages 54, 69 and 74 years old).  After flat mounting regions from the central and periph-
eral retina were excised and homogenized before Western blotting (Fig. 6A). To quan-
tify protein levels, known amounts of expressed, purified TPPP/p25 was run in parallel 
with the retinal samples (Fig. 6A). We found that TPPP/25 levels were in the range of 
0.05-013 ng TPPP/p25 per μg of extracted total protein or 0.6-4.4 µg TPPP/p25 per 
gram of tissue wet weight. These levels were lower but comparable to TPPP/p25 levels 
in brain homogenate [3]. We found that TPPP/p25 levels were significantly lower in the 
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peripheral retina compared to the central region (Fig 6A and B). Based on the associ-
ation between TPPP/p25 and tubulin acetylation [5, 35], we also determined the acet-
ylated tubulin immunoreactivity in human retinal extracts using qualitative Western blot 
(Fig. 6D). We found that while the total tubulin concentrations (determined by quanti-
tative Western blot) were similar in the central and peripheral retina and had little vari-
ability between samples (Fig. 6E), acetylated tubulin levels were highly variable with a 
trend of lower acetylation levels in the periphery (Fig. 6D). We found no difference in 
GAPDH levels which was used as loading control for the experiments (Fig. 6C). 
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DISCUSSION  
 
TPPP/p25 is an oligodendrocyte specific neomorphic moonlighting protein with 
physiological functions involving the enhancement of acetylation and bundling of mi-
crotubules and the maintenance of the zinc-rich myelin sheath [2, 3, 5, 15-17]. In pa-
thology, TPPP/p25 interacts with different proteins like alpha-synuclein [11, 36-38] 
forming inclusions [4, 11]. As such TPPP/p25 has multitude of effects that can maintain 
health or lead to disease. Zinc binds to TPPP/p25 and alters its levels [15, 17]. There-
fore, in tissues where changes in zinc levels play a significant role, interaction between 
TPPP/p25 and zinc can significantly alter its normal and/or pathological function. In the 
eye, especially in the retina, zinc levels are altered by light dark adaptation [39] or 
nerve injury [19] and this zinc could alter the levels of proteins like TPPP/p25. In this 
study, we found that TPPP/p25 has a selective expression in cells resembling ama-
crine cells and synaptic terminals in the IPL of human as well as mice. We also found 
that elevated zinc, though oral supplementation, can affect TPPP/p25 level, suggesting 
that TPPP/p25 may play a role in the organization and reorganization of retinal con-
nection at least partly through promoting tubulin acetylation. 
 
As expected we have detected TPPP/p25 in the oligodendrocytes in the ON as in brain 
tissue, but not in lamina cribrosa, which stop oligodendrocyte migration in the retina 
[26-28]. This observation underlines the specificity of the polyclonal and monoclonal 
TPPP/p25 antibodies used in this and several previous studies for the identification of 
TPPP/p25 in oligodendrocytes and as a hallmark protein for synucleinopathies  [5, 11, 
37, 38].  
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There were two major findings in our immunohistochemical studies. We identified 
TPPP/p25 immunoreactivity in some but not all cell bodies at the inner and outer edges 
of the IPL, and we found intense punctate labelling in the IPL in striations S1, S3 and 
S5 both in human and mouse retina (Fig. 1 and 4). Previously TPPP/p25 was identified 
in other retinal layers as well [40, 41], which could be due to the different sam-
pling/methodologies used in different laboratories. The cells adjacent to the IPL in the 
INL are amacrine cells [33], and can be classified in a number of ways into 30-46 dif-
ferent subtypes based on their dendritic arborisation and neurotransmitter content [30]. 
Therefore, we propose that the cell bodies positive to TPPP/p25 are amacrine cells: 
those in the GCL are probably displace amacrine cells [42] while those with projections 
between the IPL and the OPL are interplexiform amacrine cells [43] (Fig 1 and 4). 
Some of the TPPP/p25 cells contain GABA while others contain glycine as neurotrans-
mitter, but not all GABA or glycine positive cells contain TPPP/p25 (Fig. 5). Whether 
TPPP/p25 positive cells represent a new subclass of amacrine cells is yet to be deter-
mined. In the IPL TPPP/p25 appears to be postsynaptically located (Fig. 1 and 5). 
Lamina S5 is of special interest because enlarged presynaptic rod bipolar boutons 
were found to be synaptophysin rich, which are surrounded exclusively by amacrine 
cell processes [44, 45] and that is what we found in our experiments too (Supplemen-
tary Figure S2). TPPP/p25 often co-localized with acetylated tubulin (Fig. 2), which 
suggests that TPPP/p25 plays a role in organizing and/or reorganizing synaptic con-
nection and as such visual integration through regulating the acetylation of the micro-
tubule network. Our finding on TEM showed that in the IPL TPPP/p25 was in boutons 
containing few synaptic vesicles and not in the synaptic vesicle rich presynaptic termi-
nals of a bipolar cell. As postsynaptic ganglion cell contains no synaptic vesicles, this 
finding supports the idea that TPPP/p25 positive boutons belong to amacrine cells [46]. 
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Interestingly, the level of TPPP/p25 in the retina was comparable to that in the brain 
and higher than in most other tissues [40].  
 
Finally, the fact that TPPP/p25 and acetylated tubulin levels are significantly altered by 
zinc supplementation suggest that changes in zinc levels associated to physiological 
[39] or pathological conditions [19] can influence the organization and reorganization 
of the synaptic network in the IPL. The most likely mechanism behind the increase in 
TPPP/p25 levels is the reported zinc involvement in stabilization of the protein [17].  
 
CONCLUSION 
We found that TPPP/p25 is localized to specific areas of the retina and that significant 
differences do exist between the levels of TPPP/p25 with or without oral zinc supple-
mentation. The co-localization and simultaneous change of TPPP/p25 and acetylated 
tubulin by zinc supports a microtubule-related function. However, since TPPP/p25 is 
known to increase the aggregation of proteins like alpha-synuclein [10, 11, 36], ele-
vated TPPP/p25 levels may also be involved in synaptic dysfunction in the inner retina 
and may play a role in nerve injury [19]. Therefore, the zinc-mediated TPPP/p25 in-
crease may contribute to normal as well as pathological conditions.  
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FIGURE LEGENDS 
Figure 1: Immunolocalization of TPPP/p25 in mice retina. (A1) TPPP/p25 immunoreactivity 
(green) is strongly associated with oligodendrocyte-rich myelinated optic nerve. The intensive 
TPPP/p25 labelling of cells and projections in the optic nerve stops close to its entry into the 
eye. On the retinal cross-section, the IPL shows high immunoreactivity. Co-labelling with acet-
ylated tubulin (red) shows acetylation in the optic nerve throughout the nerve-fibre network into 
the RNFL.  (A2) A magnified image of a TPPP/p25 enriched cell of the optic nerve highlights 
the co-localization (yellow) of TPPP/p25 (green) and acetylated tubulin (red). (B1-4) Retinal 
cross-section showing immunolocalization of TPPP/p25 in the retina and co-localization with 
acetylated tubulin. (B1) Cell nuclei staining with DAPI (blue). (B2) TPPP/p25 labelling (green) 
is present in the RNFL, IPL and in few retinal neurons adjacent to IPL. Immunoreactive cells 
of INL are indicated by white arrows. (B3) Acetylated tubulin (red) strongly labels the RNFL, 
IPL, OPL and dispersed filamentous immunoreactivity is present in the nuclear layers. (B4) 
The merged image shows the co-localisation of TPPP/p25 and acetylated tubulin mainly in the 
IPL but not in the OPL of the retina. Scale bars = 20 µm (C) A maximum projection of a confocal 
z-stack shows TPPP/p25 immunoreactivity (green) of selected cells (white arrows) both in the 
INL and GCL and in neurites in the IPL. Scale bar = 10 µm (D) Interplexyform projections, 
extending from IPL to OPL (white arrow), were also TPPP/p25 positive. Scale bar = 10 µm (E) 
The magnified image shows the punctate appearance of TPPP/p25 (green) in the IPL. Double 
labelling with acetylated tubulin (red) highlighted several acetylated filaments which are not 
TPPP/p25 immunoreactive. Scale bar = 20 µm (F) TPPP/p25 (green) and anti-synaptophysin 
(red) double labelling showed no co-localisation. Most evidently in sublamina S5, the anti-syn-
aptophysin positive neurites are in close vicinity of the TPPP/p25 immunopositive dendritic 
network. Scale bar = 20 µm (G) The co-labelling of TPPP/p25 (green) and calbindin (magenta) 
identifies specific layers of the IPL. TPPP/p25 enriched neuritis are predominantly localized in 
the sublaminas S1, S3 and S5 while calbindin labelled sublaminas S2, S3 and S4. TPPP/p25 
positive cells did not appear to co-localise with calbindinh(white arrow). Scale bar = 20 µm 
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Figure 2: Co-localization of TPPP/p25 and acetylated tubulin in the mice retina. (A) Several 
oligodendrocytes in the myelinated ON were enriched in both TPPP/p25 (green) and acety-
lated tubulin (red) immunoreactivity. The nucleus was labelled by DAPI (blue). A line-scan 
across these cells identified co-localization (white arrowheads) within the cells bodies. The 
arrow indicates the site of the line-scan and the arrowheads identify corresponding areas on 
the fluorescent image and the line-scan. (B) A line scan across an amacrine cell and the adja-
cent S1 sublamina of the IPL showed variable co-localizations. The white arrowheads indicate 
co-localization while the red arrowhead indicates the lack of co-localization. Scale bar = 10 
µm. 
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Figure 3: The effects of zinc supplementation on TPPP/p25 levels. Qualitative determination 
of (A) TPPP/p25 and (B) acetylated tubulin immunoreactivity in the IPL of wild type control in 
lab water (dashed bars), transgenic on lab water (empty bar) or transgenic animals on zinc 
supplemented water (black bar) at the central and peripheral retinal locations. Experiments 
were conducted in triplicates and represented as average ± SEM; * represents p<0.05, deter-
mined by 2-way Anova. 
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Figure 4: Immunolocalization of TPPP/p25 in human retina. (A) Similar to mice, TPPP/p25 
immunolocalization revealed trilaminar distribution in the IPL and scattered immunoreactivity 
in the OPL in the human retina. (B) TPPP/p25 labelling is present in punctate structures in the 
IPL and some but not all amacrine cell bodies (white arrows). Interplexyform projections are 
also present (red arrow). (C) Imaging the amacrine cell layer on a flat-mount retina highlights 
that only a small proportion of amacrine cells are enriched in TPPP/p25. Scale bar = 20 µm. 
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Figure 5:  Identification of TPPP/p25 positive amacrine cells based GABA and Glycine con-
tent. Sections of human retinas were co-labelled with TPPP/p25 (green) and (A) Glycine (red) 
or (B) GABA (red). (A) Glycine labelled several cell bodies both in the inner and outer aspect 
of the IPL (arrows), some of these were TPPP/p25 positive (white arrow) while others did not 
contain TPPP/p25 (red arrow). (B) Similarly, many GABA-ergic cells were observed on both 
aspects of IPL (arrows), out of which a some were expressing TPPP/p25 (white arrow), while 
others did not (red arrow). (C) In the IPL TPPP/p25 (green) and GABA (red) are localized to 
opposing synaptic structures (red arrow). (D) Immunogold labeling clearly identify TPPP/p25 
in the postsynaptic boutons (black arrows), opposite the synaptic vesicle-rich presynaptic ter-
minal. Scale bars on A, B, C = 10 µm; on D = 10 nm. 
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Figure 6: Determination of TPPP/p25 concentration by quantitative Western blot of human 
retinal extracts. (A) Representative Western blot images: 25 and 50 μg retinal homogenate 
were loaded onto SDS-PAGE along with different concentrations of human recombinant 
TPPP/p25. (B) Quantification of the Western blot. (C) As a loading control, glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used. (D) Determination of relative concentration of 
acetylated tubulin. (E) Tubulin concentration was determined by using purified bovine brain 
tubulin. Concentrations were determined by densitometric analysis using ImageJ v1.48. The 
data are presented as mean ± standard deviation, n=3. Statistical differences were determined 
by using two-tailed, unpaired Student's t-test and values were considered to be significant if 
the p value was <0.05 (*). 
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Antigen  Host  Working dilution  Source 
TPPP/p25 
(Polyclonal) 
 Rat  1:200 (IHC) 1:5000 (Western blot) 
 raised in house 
[1] 
TPPP/p25 
(Monoclonal) 
 Mouse  1:200 (IHC)  raised in house [2] 
TPPP/p25 
(Polyclonal) 
 Rabbit  1:100 (Immuno gold)  Novusbio NBP1-80962 
Acetylated Tu-
bulin (Mono-
clonal) 
 
Mouse 
 1:200 (IHC) 
1:5000 (Western blot) 
 Sigma 
T6793 
Tubulin 
(Monoclonal) 
 Mouse  1:5000 (Western blot)  Sigma T9026 
Calbindin 
(Monoclonal) 
 Rabbit  1:2000 (IHC)  Sigma C2724 
Synaptophysin 
(Monoclonal) 
 Rabbit  1:300 (IHC)  MerckMillipore #04-1019 
GABA 
(polyclonal) 
 Rabbit  1:1000 (IHC)  Sigma A2052 
Glycine 
(polyclonal) 
 Rabbit  1:100 (IHC)  donated by D.V.Pow (raised in house [3]) 
GAPDH  Mouse  1:5000 (Western blot)  Calbiochem CB1001 
Supplementary table 1. List of primary antibodies used  
Antigen specificity, host, source of provenience and working dilution used for 
immunohistochemistry (IHC), immune gold staining or western blot are listed for 
the primary antibodies. 
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Striation  TPPP/p25  Calbindin  Synaptophysin  Ac-tubulin 
S5 (61-100%)  +++    +  ++ 
S4 (53-60%)  +  +  ++  ++ 
S3 (30-52%)  ++  +  ++  ++ 
S2 (23-29%)  +  +  +++  ++ 
S1 (0-22%)  +++    +++  +++ 
Supplementary table 2. Summary of qualitative fluorescence intensities of 
different proteins in the IPL in mice eye. TPPP/p25 fluorescence intensity iden-
tifies 5 striations in the IPL (S1-S5), with the width of striations noted in the 
brackets. In these striations the immunolabelling intensity of several proteins 
was assessed and a summary of fluorescence intensities is listed in the table. 
Intensity gradient for each protein is marked by crosses; the number of crosses 
between columns are not comparable. 
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Supplementary figure 1. Immunolocalization of acetylated tubulin in mouse ret-
ina. 
Acetylated tubulin (red) is visible throughout all layers of the inner retina in a 
specific distribution: elongated filamentous structures are observed in the 
RNFL, interlacing projections form a compact functional network in the IPL, 
and cytoplasmic distribution around nuclei (blue) are all providing stability of 
the cytoskeleton and synaptic connections. Scale bar = 50 µm 
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Supplementary figure 2. Immunolocalization of TPPP/p25 and synaptophysin in 
lamina S5 of mouse retina. A tilted section across the IPL exposed the sublamina 
S5 containing enlarged synaptophysin labelled presynaptic boutons (red) and 
TPPP/p25 labelled postsynaptic processes (green). Scale bar = 10 µm 
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